In humans, mutations in CAV1 encoding the caveolae protein caveolin-1, lead to a near complete loss of subcutaneous and visceral AT, associated with insulin resistance and dyslipidemia, therefore referred as BSCL3 (49). The gene discussed is CAV1; the disease is metabolic syndrome.